Cooper Laurence James Neil 4
4 · ZIOPHARM ONCOLOGY INC · Filed Nov 9, 2017
Insider Transaction Report
Form 4
Cooper Laurence James Neil
Chief Executive Officer
Transactions
- Purchase
Common Stock
2017-11-08$4.68/sh+6,440$30,139→ 1,083,731 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.66 to $4.71, inclusive.The Reporting Person undertakes to provide to the Issuer, any stockholder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.